Table 1.
Extraction solvent | Country | Type | Model | Efficient doses | Results | References |
---|---|---|---|---|---|---|
Antisteatotic activity | ||||||
| ||||||
Water | China | In vitro | DL-ethionine-treated rat hepatocytes | 1, 5, 10, 20, and 50 μg/ml | Apolipoprotein B ↑ liver TG ↓ lipid droplet ↓ | [13] |
In vivo | High-fat diet rats | 2.26 g/kg | Liver TG↓ | [17] | ||
| ||||||
Ethanol | South Korea | In vitro | FFA-treated HepG2 | 100 μg/ml | Lipid droplet ↓ | [11] |
In vitro | NEFAs-treated HepG2 | 300 μg/ml | Lipid droplet ↓ FAS mRNA & protein ↓ ACC mRNA & protein ↓ | [12] | ||
| ||||||
Methanol | China | In vivo | High-fat diet rats | 300, 600 mg/kg | Liver weight↓ Liver weight/body weight ratio↓ Liver TG ↓ lipid droplet ↓ | [16] |
South Korea | In vivo | Benzo(a)pyrene-injected rats | 0.15 g/kg | Liver TG↓ | [14] | |
South Korea | In vitro | Tunicamycin-treated HepG2 | 10, 50, and 100 μg/ml | TG ↓ VLDL receptor ↓ Apolipoprotein B ↑ | [15] | |
In vitro | Palmitate -treated HepG2 | 10, 50, and 100 μg/ml | Hepatic lipogenic genes (FAS, ACC, and GPAT) ↓ TG ↓ VLDL receptor ↓Apolipoprotein B ↑ | |||
In vivo | Tunicamycin-injected mice | 50, 100 mg/kg | Liver TG ↓VLDL receptor ↓Apolipoprotein B ↑ | |||
In vivo | High-fat diet mice | 100, 300 mg/kg | Hepatic lipogenic genes ↓liver TG ↓VLDL receptor↓ Apolipoprotein B ↑ | |||
| ||||||
Antioxidant activity | ||||||
| ||||||
Water | South Korea | In vitro | Palmitate -treated HepG2 | 100 μg/ml | ROS ↓ TBARS ↓ | [21] |
| ||||||
Ethanol | South Korea | In vitro | tert-Butyl hydroperoxide-induced HepG2 | 0.05, 0.1 mg/ml | Free radicals ↓ Superoxide anions ↓ MDA ↓ | [20] |
In vivo | tert-Butyl hydroperoxide-induced rats | 1 g/kg | Liver MDA ↓ | |||
| ||||||
Methanol | China | In vivo | High-fat diet rats | 300, 600 mg/kg | Serum MDA ↓ Serum SOD ↑ | [16] |
South Korea | In vivo | High-fat diet rats | 100, 200, and 300 mg/kg | Serum MDA ↓ | [19] | |
| ||||||
Antilipoapoptotic activity | ||||||
| ||||||
Water | South Korea | In vitro | Palmitate -treated HepG2 | 100 μg/ml | Apoptotic cells ↓ sub-G1 cells ↓ BAX ↓ Bcl-2 ↑ pJNK ↓ | [21] |
South Korea | In vitro | Palmitate -treated HepG2 | 10, 100 μg/ml | Sub-G1 cells ↓ | [23] | |
| ||||||
Ethanol | South Korea | In vitro | NEFAs-treated HepG2 | 300 μg/ml | MAPK8 mRNA ↓ p-JNK ↓ BAX ↓ Bcl-2 ↑ Cleaved caspase-9 ↓ Cleaved caspase-3↓ |
[12] |
South Korea | In vitro | FFA-treated HepG2 | 100 μg/ml | p-JNK ↓ PUMA mRNA & protein ↓ BAX ↓ Bcl-2 ↑ Cleaved caspase-3 ↓ Cleaved caspase-9 ↓ | [11] | |
| ||||||
Hepatoprotective activity | ||||||
| ||||||
Water | South Korea | In vivo | High-fat diet mice | 100, 300 mg/kg | Serum AST ↓ Serum ALT ↓ | [26] |
China | In vivo | High-fat diet mice | 2.26 g/kg | Serum AST ↓ Serum ALT ↓ | [17] | |
South Korea | In vivo | Benzo(a)pyrene-injected rats | 9 g/kg | Serum AST ↓ Serum ALT ↓ Liver AST ↓ Liver ALT ↓ | [27] | |
| ||||||
Ethanol | South Korea | In vivo | tert-Butyl hydroperoxide-induced rats | 1 g/kg | Serum AST ↓ Serum ALT ↓ | [20] |
| ||||||
Methanol | China | In vivo | High-fat diet rats | 150, 300, and 600 mg/kg | Serum AST ↓ Serum ALT ↓ | [16] |
South Korea | In vivo | High-fat diet rats | 100, 200, and 300 mg/kg | Serum AST ↓ Serum ALT ↓ | [19] | |
South Korea | In vivo | Acetaminophen-injected rats | 250, 500 mg/kg | Serum AST ↓ Serum ALT ↓ | [28] | |
| ||||||
Anti-inflammatory and antifibrotic activity | ||||||
| ||||||
Water | South Korea | In vivo | High-fat diet mice | 100 mg/kg | Serum adiponectin↑ | [26] |
| ||||||
Ethanol | South Korea | In vitro | NEFAs-treated HepG2 | 300 μg/ml | NF-κB p65(p65) ↓ p-p65 ↓ COX-2 ↓ iNOS ↓ | [12] |
South Korea | In vitro | Human hepatic stellate cells | 0.02, 0.1 mg/ml | TIMP-1↓ | [29] | |
| ||||||
Methanol | South Korea | In vitro | Tunicamycin-treated HepG2 | 10, 50, and 100 μg/ml | GRP78 mRNA↓ CHOP mRNA↓ XBP-1 mRNA↓ IL-6 mRNA ↓ TNF-α mRNA↓ MCP-1 mRNA ↑ | [15] |
In vitro | Palmitate -treated HepG2 | 10, 50, and 100 μg/ml | ||||
In vivo | Tunicamycin-injected mice | 50, 100 mg/kg | Liver GRP78 mRNA↓ liver CHOP mRNA↓ liver XBP-1 mRNA↓ liver IL-6 mRNA ↓ Liver TNF-α mRNA↓ liver MCP-1 mRNA ↑ |
|||
In vivo | High-fat diet mice | 100, 300 mg/kg | ||||
China | In vivo | High-fat diet rats | 150, 300, and 600 mg/kg | Liver collagen deposition↓ | [16] | |
| ||||||
Hypolipidemic activity | ||||||
| ||||||
Water | South Korea | In vitro | Microsome from rat liver | 10 μl | Liver ACAT↓ Liver HMA-CoA reductase↓ | [30] |
South Korea | In vivo | High-fat diet mice | 100 mg/kg | Serum TG ↓ Serum TC ↓ Serum LDL ↓ Serum HDL ↑ Serum HDL/LDL ↑ | [26] | |
China | In vivo | High-fat diet rats | 2.26 g/kg | Serum TC ↓ Serum TG ↓ Liver TC ↓ Serum HDL ↑ Liver HMG-CoA reductase ↓ |
[17] | |
| ||||||
Methanol | China | In vivo | High-fat diet rats | 300, 600 mg/kg | Serum TC ↓ Serum TG ↓ Liver TC ↓ | [16] |
South Korea | In vivo | Benzo(a)pyrene-injected rats | 0.15 g/kg | Serum TG↓ Serum TC↓ liver TC↓ | [14] | |
South Korea | In vivo | High-fat diet rats | 100, 200, and 300 mg/kg | Serum LDL ↓ | [19] | |
| ||||||
Antiobesity activity | ||||||
| ||||||
Water | China | In vivo | Goto-Kakizaki rats | 3 mg/g | Body weight↓ | [31] |
South Korea | In vivo | High-fat diet mice | 100 mg/kg | Body weight↓ Total fat weight/ Body weight↓ Adipocyte size↓ Serum Adiponectin↑ |
[32] | |
South Korea | In vitro | 3T3-L1 cells | 10 mg/ml | Proliferation↓ Differentiation↓ | [33] | |
China | In vitro | Caco-2/TC7 transfected with human ApoA-IV promoter | 1 mg/ml | ApoA-IV promoter activity↑ ApoA-IV mRNA↑ | [34] | |
3T3-L1 cells | 1, 10 mg/ml | TG↓ | ||||
| ||||||
Ethanol | South Korea | In vitro | OP9 cells | 20, 40 μg/ml | PPARγ protein↓ PPARγ mRNA↓ C/EBPα mRNA↓ C/EBPβ protein↓ |
[35] |
| ||||||
Methanol | China | In vivo | High-fat diet rats | 300, 600 mg/kg | Epididymal fat weight ↓ Epididymal fat weight/body weight↓ | [16] |
| ||||||
Hypoglycemic activity | ||||||
| ||||||
Water | China | In vitro | BBMV | 1 mg/ml | Intestinal glucose absorption ↓ | [36] |
Hs68 cells | 0.01, 0.1, and 1 mg/ml | Fibroblast glucose uptake ↑ | ||||
3T3-L1 cells | 0.01, 0.1, and 1 mg/ml | Adipocyte glucose uptake ↑ | ||||
China | In vivo | Streptozotocin-induced mice | 1.5, 3 g/kg | Serum glucose ↓ Serum insulin ↑ | [37] | |
South Korea | In vivo | Streptozotocin-induced rats | 61.25 mg/kg | Serum glucose ↓ | [38] | |
China | In vivo | Goto-Kakizaki rats | 3 mg/g | Fasting serum glucose ↓ glucose tolerance ↑ | [31] | |
South Korea | In vivo | High-fat diet mice | 100 mg/kg | Serum adiponectin↑ Liver PGC-1α, ERRγ, G6Pase, PEPCK mRNA↓ | [26] | |
| ||||||
Ethanol | South Korea | In vitro | 3T3-L1 cells | 50 μg/ml | PPARγ agonist activity ↑ | [39] |
| ||||||
Methanol | China | In vivo | High-fat diet rats | 300, 600 mg/kg | Fasting serum glucose ↓ insulin sensitivity index ↑ Insulin resistance index ↓ |
[16] |
| ||||||
Alcohol | China | In vitro | 3T3-L1 cells | 25, 50, and 100 μg/ml | Adipocyte glucose uptake ↑ | [40] |
α-Glucosidase assay | 25 μg/ml | α-Glucosidase activity ↓ | ||||
| ||||||
Ethyl acetate | China | In vivo | High-fat diet and streptozotocin-induced mice | 100 mg/kg | Fasting serum glucose ↓ serum insulin ↑ serum HbA1c ↓ IRS-1 protein ↑ Akt protein ↑ |
[41] |